Matsumoto, Japan

Koichi Kubota


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Nagano, JP (1989)
  • Matsumoto, JP (1991 - 1993)

Company Filing History:


Years Active: 1989-1993

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Koichi Kubota: Innovator in Benzofuran and Benzothiophene Derivatives**

Introduction

Koichi Kubota is an accomplished inventor based in Matsumoto, Japan. With a total of four patents to his credit, Kubota has made significant contributions to the development of anti-hyperuricemia agents. His innovative work focuses on creating compounds that serve as effective diuretics without the common side effects associated with elevating serum uric acid levels.

Latest Patents

Among Kubota's latest patents are a series of benzofuran and benzothiophene derivatives. These compounds are characterized by a unique structure, which is achieved by substituting the third position of 2-lower alkyl-benzofuran or 2-lower alkyl-benzothiophene with various substituted compounds. This innovation offers substantial benefits in the treatment of hyperuricemia and showcases Kubota's commitment to addressing medical needs through scientific innovation.

Career Highlights

Kubota is currently affiliated with Kotobuki Seiyaku Co., Ltd., where he continues to drive research and development of pharmaceutical products. His contributions are pivotal in advancing the frontiers of medical treatments and enhancing the quality of life for patients suffering from hyperuricemia and related conditions.

Collaborations

Throughout his career, Koichi Kubota has collaborated with notable colleagues such as Tsuyoshi Tomiyama and Akira Tomiyama. These partnerships reflect a collaborative spirit within the scientific community, aimed at propelling innovations that can lead to breakthrough healthcare solutions.

Conclusion

Koichi Kubota's inventive spirit and dedication to enhancing medical treatments through his patented benzofuran and benzothiophene derivatives illustrate the significance of innovation in the pharmaceutical field. His work exemplifies how targeted research can yield practical benefits, improving the lives of many individuals affected by hyperuricemia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…